Daily Archives: November 24, 2020

Gaucher Disease Treatment Market Booming in Americas & Europe With Top Players, Growth, Size, Major Drivers and Forecast to 2026 | Genzyme…

Posted: November 24, 2020 at 8:56 pm

The Global Gaucher Disease Treatment Market report provides a holistic evaluation of the market for the forecast period (20182026). The report comprises of various segments as well an analysis of the trends and factors that are playing a substantial role in the market. These factors; the market dynamics involve the drivers, restraints, opportunities and challenges through which the impact of these factors in the market are outlined. The drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The Global Gaucher Disease Treatment Market study provides an outlook on the development of the market in terms of revenue throughout the prognosis period. Major Players included in this report are as follows Genzyme Corporation, Pfizer, Inc., Shire Human Genetics Therapies, Inc., and Actelion Pharmaceuticals Ltd. (acquired by Johnson & Johnson in June 2017). There are various drugs in pipeline of companies such as Lixte Biotechnology Holdings Inc, JCR Pharmaceuticals Co Ltd, Pharming Group NV and Orphazyme ApS, for Gaucher disease treatment.

Get Free PDF Brochure Of this Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1225

Global Gaucher Disease Treatment Market: Scope of the Report

This report provides an all-inclusive environment of the analysis for the Global Gaucher Disease Treatment Market. The market estimates provided in the report are the result of in-depth secondary research, primary interviews and in-house expert reviews. These market estimates have been considered by studying the impact of various social, political and economic factors along with the current market dynamics affecting the Global Gaucher Disease Treatment Market growth.

Global Gaucher Disease Treatment Market: Competitive Landscape

The market analysis entails a section solely dedicated for major players in the Global Gaucher Disease Treatment Market wherein our analysts provide an insight to the financial statements of all the major players along with its key developments product benchmarking and SWOT analysis. The company profile section also includes a business overview and financial information. The companies that are provided in this section can be customized according to the clients requirements.

Geographically, this report studies the top producers and consumers in these key regions

Important details covered in the report:

Data regarding the information related to the production covering these economies is provided. The report reveals information regarding each region along with the production growth in the report. Crucial details relatable to the growth rate accounted for every region in the Gaucher Disease Treatment market is revealed in the report. The study also mentions information regarding the import and export patterns, the consumption rate as well as consumption volume in the report.

Global Gaucher Disease Treatment Market: Research Methodology

The research methodology is a combination of primary research secondary research and expert panel reviews. Secondary research includes sources such as press releases company annual reports and research papers related to the industry. Other sources include industry magazines, trade journals, government websites and associations were can also be reviewed for gathering precise data on opportunities for business expansions in Global Gaucher Disease Treatment Market.

Customization of the Report

This report can be personalized to meet your requirements. Get in touch with our sales representative now with a guarantee to get access to a report that suits best to your business needs.

Introduction about Global Gaucher Disease Treatment Market

Global Gaucher Disease Treatment Market Size (Sales) Market Share in 2018 by Product Type (Categorization) Global Gaucher Disease Treatment Market Size (Sales) Market Share in 2018 by Application Type (End-Users) Global Gaucher Disease Treatment Growth Rate and Sales (2018-2026) Global Gaucher Disease Treatment Market Share and Sales (Volume) Comparison by Applications Global Gaucher Disease Treatment Suppliers/Players Profiles along with their Sales Data Gaucher Disease Treatment Competition by Region, Application, Type, and Suppliers/Players Defined (Value, Sales Price, and Volume) table for each geographic region under Gaucher Disease Treatment A separate table of product value, market sales, gross margin, and revenue (2014-2019) for each product type

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1225

Major Topics Covered in this Report

Chapter 1 Study CoverageChapter 2 Executive SummaryChapter 3 Market Size by ManufacturersChapter 4 Production by RegionsChapter 5 Consumption by RegionsChapter 6 Market Size by TypeChapter 7 Market Size by ApplicationChapter 8 Manufacturers ProfilesChapter 9 Production ForecastsChapter 10 Consumption ForecastChapter 11 Upstream, Industry Chain and Downstream Customers AnalysisChapter 12 Opportunities & Challenges, Threat and Affecting FactorsChapter 13 Key FindingsChapter 14 Appendix

Interested about who is winning the race of COVID-19 Vaccine. Coherent Market Insights (CMI)

provides COVID-19 Vaccine Tracker for all the latest updates about COVID-19 Vaccine.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Tel: +1-206-701-6702Email: [emailprotected]

Go here to see the original:
Gaucher Disease Treatment Market Booming in Americas & Europe With Top Players, Growth, Size, Major Drivers and Forecast to 2026 | Genzyme...

Posted in Human Genetics | Comments Off on Gaucher Disease Treatment Market Booming in Americas & Europe With Top Players, Growth, Size, Major Drivers and Forecast to 2026 | Genzyme…

Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001 – GlobeNewswire

Posted: at 8:56 pm

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that the United States Patent and Trademark Office (USPTO) onNovember 17, 2020issued a composition of matter patent, U.S. Patent No. 10,837,028,with claims directed to the AAV vector used in PR001, Prevails experimental gene therapy program for the treatment of Parkinsons disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease (nGD). The base patent term extends until October 3, 2038, excluding patent term extensions or coverage in additional related patent filings.

We are excited to make important progress this year with PR001, which is being evaluated in the Phase 1/2 PROPEL trial for patients with Parkinsons disease with GBA1 mutations and in the Phase 1/2 PROVIDE trial for patients with Type 2 Gaucher disease, said Asa Abeliovich, M.D., Ph.D., Founder and Chief Executive Officer of Prevail. We are advancing clinical development of PR001 to make a potentially transformative difference for these patients who currently have no approved treatment options.

The Company recently announced that patient dosing has continued in the Phase 1/2 PROPEL clinical trial of PR001 for PD-GBA patients, and it expects to provide the next biomarker and safety analysis on a subset of patients in the PROPEL trial by mid-2021. The Company expects to initiate enrollment of the Phase 1/2 PROVIDE clinical trial of PR001 for Type 2 Gaucher disease patients in the fourth quarter of 2020 and currently anticipates it will provide the next update on PR001 biomarker and safety data for nGD in 2021.

The U.S. Food and Drug Administration has granted Fast Track designations for PR001 for the treatment of PD-GBA and nGD. In addition, the FDA granted PR001 Rare Pediatric Diseasedesignation for the treatment of nGD, and Orphan Drugdesignation for the treatment of patients with Gaucher disease.

About Prevail TherapeuticsPrevail is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. The Company is developing PR001 for patients with Parkinsons disease with GBA1mutations (PD-GBA) and neuronopathic Gaucher disease (nGD); PR006 for patients with frontotemporal dementia withGRNmutations (FTD-GRN); and PR004 for patients with certain synucleinopathies.

Prevail was founded by Dr.Asa Abeliovichin 2017, through a collaborative effort withThe Silverstein Foundationfor Parkinsons with GBA and OrbiMed, and is headquartered inNewYork, NY.

Forward-Looking Statements Related to PrevailStatements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Examples of these forward-looking statements include statements concerning the potential for Prevails gene therapy candidates to make a transformative difference for patients with neurodegenerative diseases; the expected timing of reporting additional interim data on a subset of patients from the PROPEL trial; and the anticipated timing of enrollment of and the next update on data from the PROVIDE trial. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among others: Prevails novel approach to gene therapy makes it difficult to predict the time, cost and potential success of product candidate development or regulatory approval; Prevails gene therapy programs may not meet safety and efficacy levels needed to support ongoing clinical development or regulatory approval; the regulatory landscape for gene therapy is rigorous, complex, uncertain and subject to change; the fact that gene therapies are novel, complex and difficult to manufacture; and risks relating to the impact on our business of the COVID-19 pandemic or similar public health crises. These and other risks are described more fully in Prevails filings with the Securities and Exchange Commission (SEC), including the Risk Factors sections of the Companys most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the SEC, and its other documents subsequently filed with or furnished to the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, Prevail undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Media Contact:Lisa QuTen Bridge Communications LQu@tenbridgecommunications.com678-662-9166

Investor Contact:investors@prevailtherapeutics.com

Read the rest here:
Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001 - GlobeNewswire

Posted in Human Genetics | Comments Off on Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001 – GlobeNewswire

Top Oxford vaccinologist explains whats ahead in the war against Covid-19 – India Today

Posted: at 8:56 pm

AstraZeneca said on Monday its vaccine, developed along with the University of Oxford, could be around 90 per cent effective (File | Reuters)

In another piece of good news for the world in its fight against the Covid-19 pandemic, AstraZeneca said on Monday its vaccine, developed along with the University of Oxford, could be around 90 per cent effective under one dosing regimen -- a half dose, followed by a full dose about a month later, instead of two full doses one month apart.

India Today TV consulting editor Rajdeep Sardesai spoke to Professor Adrian Hill, Vaccinologist and Director, Jenner Institute, and Professor of Human Genetics at Oxford University, on what lies ahead in the war against Covid-19. Excerpts from an interview:

Q: Is it a day to smile?

A: Yes, we can. We had zero hospitalisation cases from the people who were vaccinated. The one dosing regimen -- a half dose, followed by a full dose about a month later, instead of two full doses one month apart -- allows more people to be vaccinated with a planned vaccine supply. I think its really good news that the world has three promising vaccine candidates at the moment (the two others being from Moderna and Pfizer).

Q: Is it correct to say the Oxford vaccine doesnt require a stringent cold chain regimen?

A: Yes, you need to store the vaccine in fridge temperatures, sometimes in deep-fridge temperatures. It can be distributed around the world using the usual immunisation distribution systems.

Q: What will be the cost of the vaccine?

A: In high-income countries, during the pandemic, it will be three dollars per vaccine. After the pandemic, the price will remain the same in low-income countries, but the manufacturers may look to make a profit in high-income countries.

Q: When will the vaccine be ready for emergency use (among health workers, etc)?

A: We will soon file for emergency use authorisation. We will work with our India partner, the Serum Institute of India, and the Drugs Controller General of India (DCGI) to see how quickly we can move. Early January will be the target. But mass vaccination will take more time. India is a big country but Serum is also the worlds biggest vaccine manufacturer.

Q: Vaccine development is a time-taking process. What explains this dramatic success?

A: Our students take 10 years. Were now into month 10. Its been different in many ways. Theres been help from funders, regulators, international agencies... We have also been allowed to overlap phases of clinical trials. About 270 people have worked night and day. Additionally, there were 19 trial sites in the UK alone. Brazil has vaccinated 10,000 people. Its going on in South Africa. The US has vaccinated 10,000 people. Kenya has started it. Serum is doing it in India.

Q: Are you already celebrating?

A: Were not yet at the finish line. But we have overcome the final fence. The next few weeks of paperwork are going to be really busy. We hope to have celebrations by the year-end.

Go here to read the rest:
Top Oxford vaccinologist explains whats ahead in the war against Covid-19 - India Today

Posted in Human Genetics | Comments Off on Top Oxford vaccinologist explains whats ahead in the war against Covid-19 – India Today

Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results – Business Wire

Posted: at 8:56 pm

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the fourth quarter and full year fiscal 2020 ended September 30, 2020.

We ended our fiscal year with record revenue and orders against the backdrop of a global pandemic and significant uncertainty, said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. While we are proud of the new products we introduced to aid in the fight against COVID-19, which complemented our revenue, it was our core synthetic biology and next-generation sequencing (NGS) product lines that drove our overarching success.

We have aggressive plans for growth and expansion in fiscal 2021 and beyond, continuing to build our foundation for sustained success across synthetic biology, NGS, biopharma and DNA data storage.



"Over the last year, we delivered on revenue, orders, margin and product pipeline in a very challenging environment, commented Jim Thorburn, CFO of Twist. We have a strong balance sheet and momentum moving into fiscal 2021, and look forward to an exciting year ahead.

Fiscal Fourth Quarter 2020 and Recent Highlights

Fiscal 2021 Financial Guidance

The following statements are based on Twists current expectations for fiscal 2021. The following statements are forward-looking, and actual results could differ materially depending on market conditions and the factors set forth under Forward-Looking Statements below. Twist does not plan to update, nor does it undertake any obligation to update, this outlook in the future.

For the full fiscal year 2021, Twist provided the following financial guidance:

Fiscal 2021 First Quarter Financial Guidance

For the first quarter of fiscal 2021, Twist provided the following financial guidance:

COVID-19 Considerations

During the three months ended September 30, 2020, financial results of the Company were not significantly affected by the COVID-19 outbreak. However, the extent to which the COVID-19 outbreak affects Twists future financial results and operations is subject to a high degree of uncertainty and will depend on future developments, including the duration, spread and treatment of the outbreak domestically and abroad.

Conference Call Information

The company plans to hold a conference call and live audio webcast for analysts and investors today at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the companys business. The call can be accessed by dialing (866) 688-0947 (domestic) or (409) 217-8781 (international) and refer to the conference ID 2947139. A telephonic replay of the conference call will be available beginning approximately four hours after the call through November 30, 2020 and may be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay conference ID is 2947139. The webcast replay will be available for two weeks.

Given the circumstances globally, it is recommended to dial-in at most 15 to 20 minutes prior to the call start to reduce waiting times. If a participant will be listen-only, they are encouraged to listen via the webcast on Twists investor page.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by writing DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

Investor Relations Information

Twist uses the investor relations section on its website as a means of complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor Twist's investor relations website in addition to following Twist's press releases, SEC filings, and public conference calls and webcasts.

Legal Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements under the headings Fiscal 2021 Financial Guidance and Fiscal 2021 First Quarter Financial Guidance, future growth and expansion plans and Twists other expectations regarding its future financial performance, the impact of the COVID-19 pandemic on Twists future financial performance, and Twists ability to address the challenges posed by the business and economic impacts of COVID-19 pandemic, diversification and revenue growth across all product categories, introduction of new products, the use of our products by the healthcare sectors for the potential detection and treatment of diseases, and expectations regarding newly announced partnerships. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twists actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties of the duration, extent and impact of the COVID-19 pandemic, including any reductions in demand for our products (or deferred or canceled orders) globally or in certain regions; the ability to attract new customers and retain and grow sales from existing customers; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology could make the products Twist is developing obsolete or non-competitive; uncertainties of the retention of significant customers; supply chain and other disruptions caused by the COVID-19 pandemic or otherwise; risks of third party claims alleging infringement of patents and proprietary rights or seeking to invalidate Twists patents or proprietary rights; and the risk that Twists proprietary rights may be insufficient to protect its technologies. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Twists business in general, see Twists risk factors set forth in Twists Annual Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) on August 12, 2020 and subsequent filings with the SEC. Additional risk factors may be described in the Risk Factors section of Twists Annual Report on Form 10-K to be filed with the SEC on or about November 25, 2020. In addition, many of the foregoing risks and uncertainties are, and could be, exacerbated by the COVID-19 pandemic and any worsening of global or regional business and economic environment as a result. We cannot at this time predict the extent of the impact of the COVID-19 pandemic and any resulting business or economic impact, but it could have a material adverse effect on our business, financial condition, results of operations and cash flows. Any forward-looking statements contained in this press release speak only as of the date hereof, and Twist Bioscience specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Twist Bioscience Corporation

Condensed Consolidated Statements of Operations


(in thousands, except per share data)

Three months ended September 30,

Twelve months ended September 30,






































Read the original:
Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results - Business Wire

Posted in Human Genetics | Comments Off on Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2020 Financial Results – Business Wire

What’s New In The Islands Of The Bahamas This Winter – PRNewswire

Posted: at 8:55 pm

NASSAU, Bahamas, Nov. 24, 2020 /PRNewswire/ --It's Better in The Bahamas this winter as the country welcomes international visitors to enjoy the sun, sand and sea. From hotel reopenings with exciting deals to the Bahama Out Islands Promotion Board's $500 air credit, The Bahamas is the perfect destination for travelers seeking an escape from the cold this holiday season.


Ministry of Tourism Launches Interactive Island Guide In an effort to make planning a safe, much-needed Bahamian getaway more seamless, the Ministry of Tourism introduced an interactive map that provides visitors with an island-by-island guide of the most up-to-date guidelines, including business hours of operations, beach access and more.

Hotel Reopenings Across The Bahamas Atlantis Paradise Island is scheduled to reopen on December 10, 2020, and Eleuthera's French Leave Resort is set to reopen December 15, 2020. Grand Hyatt Baha Mar and Exuma's Grand Isle Resort & Spa are both scheduled to reopen December 17, 2020. Sandals Royal Bahamian Resort will reopen January 28, 2021, while Sandals Emerald Bay will reopen February 1, 2021.

Exuma and Long Island Airport Expansions Exuma International Airport is getting a major upgrade. The project, which is slated to begin next month, will expand the terminal from 2,000 square feet to 60,000 square feet. The country is planning additional airport expansions for Long Island, which is expected to be completed in March 2022. The project will expand the airport's runway from 4,000 feet to 6,500 feet.


For a complete, up-to-date listing of deals and packages for The Bahamas, visitwww.bahamas.com/deals-packages.

Out Island Black Friday Air Credit The Bahama Out Islands Promotion Board is offering a $500 air credit this Black Friday to help travelers plan their next Bahamian vacation. Credit is applicable when pre-booking an air-inclusive 7-night package at a participating Bahama Out Islands Promotion Board member hotel. Travelers must book by November 30, 2020 and travel by January 31, 2021. Blackout dates apply.

Atlantis First Night Free Package In celebration of the resort's reopening, Atlantis is offering guests their first night free with a two-night minimum stay. Bookable between November 10 22 and valid for stays between December 10 17.

Baha Mar Dream Away and Getaway Package Grand Hyatt Baha Mar is offering guests 20 percent off just in time for the resort's December 17 reopening. Book by December 6, 2020 for stays through April 4, 2021.

Coral Sands Resort Credit - The beloved Harbour Island resort is offering a $100 resort credit inclusive of daily continental breakfast for two and access to all non-motorized water sports when staying for a minimum of two nights. The offer is valid through December 15, 2020.


Travel Weekly'sMagellan Awards Recognizes The Bahamas' Still Rockin' Campaign The Bahamas Ministry of Tourism & Aviation's Still Rockin' campaign was awarded the best destination advertising/marketing campaign. In the aftermath of Hurricane Dorian, the campaign highlighted The Bahamas' 14 major islands unimpacted by the storm, which contributed to the country's record-breaking year of 7.2 million visitors in 2019. The awards also recognized the Ministry's From Bahamas With Love campaign, which was awarded silver in the destination marketing TV commercial category.

ABOUT THE BAHAMASWith over 700 islands and cays and 16 unique island destinations, The Bahamas lies just 50 miles off the coast of Florida, offering an easy fly away escape that transportstravelersaway from their everyday. The Islands of The Bahamas have world-class fishing, diving, boating and thousands of miles of the earth's most spectacular water and beaches waiting for families, couples and adventurers. Explore all the islands have to offer atwww.bahamas.comor onFacebook,YouTubeorInstagramto see why It's Better in The Bahamas.

PRESS INQUIRIESAnita Johnson-PattyGeneral Manager, Global CommunicationsBahamas Ministry of Tourism & Aviation[emailprotected]

Weber ShandwickPublic Relations[emailprotected]

SOURCE Bahamas Ministry of Tourism & Aviation


View original post here:

What's New In The Islands Of The Bahamas This Winter - PRNewswire

Posted in Bahamas | Comments Off on What’s New In The Islands Of The Bahamas This Winter – PRNewswire

INSIGHT: From persecution to prison to poverty a political refugee’s five-year ordeal in The Bahamas – Bahamas Tribune

Posted: at 8:55 pm


Fleeing his native Gambia in fear of extra-judicial execution, Ousman Bojang accepted a friends invitation to take refuge in The Bahamas. Expecting safety and protection in accordance with our international obligations, he was met instead with arbitrary detention, false imprisonment, inhumane treatment and shocking conditions. Then he was released, only to be forced into poverty by a cruel and spiteful government.

As Bojangs quest for justice finally approaches resolution, this 40-year-old father-of-two, formerly a truck driver and engineering student, is hunkered down in a friends derelict car, where he has lived for the past two years in an increasingly desperate struggle to survive. Unable to support himself following his court ordered release in 2017, because the government has refused to give him a work permit.

Bojangs ordeal began in 2015 during a very difficult political period in his country. As a youth leader for the opposition, the United Democratic Party (UDP), he was falsely arrested for organising political meetings. He was held for three days without charge before being released. But, then came a tip that he would soon be rearrested and possibly killed.

It is apparently common for the authorities in Gambia to release political prisoners publicly, then recapture and disappear them quietly while claiming they have gone into hiding. The authorities also falsely accused Bojang of being a homosexual, a crime in his country that carries a minimum sentence of 14 years and makes one a target of violence and even death at the hands of fellow citizens.

He had no choice but to flee, leaving his young family behind, first to Dakar in Senegal and then, upon the invitation of a friend, to The Bahamas where he entered - legally - on a 14-day visa on December 5, 2015. After several attempts to find a UN High Commissioner and apply for political asylum, he presented himself to The Bahamas Immigration Department, but was told they were too busy during the holiday season to help him.

When, after several attempts, he finally got before an immigration officer on December 30 and explained he was in The Bahamas to apply for asylum as he feared for his life in Gambia, instead of being offered help as mandated by international law, he was summarily taken into custody without explanation.

Held for 531 days, between December 30, 2015 and June 16, 2017 in terrible and inhuman conditions at both Fox Hill Prison and the Carmichael Road Detention Centre, Bojang was never charged with anything, never convicted or even brought before a court of law.

In sworn evidence, he told of the horrifying treatment and conditions to which he was subjected while in custody. Overcrowding at the Detention Centre was endemic, with his dorm occupied by 300 to 400 people and not enough beds to accommodate them. For the first two weeks I slept on the floor until I found a dirty old mattress which I used after that, he said.

Bojang had little to eat, was forced to drink stinking tap water and had to endure terrifying nighttime drills. Every night we were awakened at around midnight by the Defence Force officers and we all had to stand outside, sometimes for hours, sometimes all night. The defence force officers didnt care whether it was cold or not, he said.

Then, the government sought to rid itself of this asylum seeker in the most shocking and cynical way. On May 25, 2016 they tried to forcibly return him to Gambia back to the very country where he had been persecuted and from which he fled in fear. They did this without a Deportation Order, even though required by law. Instead, they tried to trick Bojang, falsely claiming his family had sent him a ticket home.

The truth is that Immigration hadnt even bothered to secure a ticket for his first leg of his journey, much less a connecting flight to Africa. Instead they just bundled him on a plane to Havana. When the Cuban authorities realised this, they sent him immediately back to The Bahamas.

He was returned to the Carmichael Detention Centre, but soon moved to Fox Hill Prison, as the authorities said a hurricane was coming. The first night I was placed in a small balcony room with no beds with 14 other men. The room had no walls. It was like a balcony with iron bars around. The area was flooded so we had nowhere to sleep. The following night I was placed in a small cell approximately 3x8 square feet with over 20 other prisoners. There were no beds, mattress or blankets. We had to sleep on the concrete floor. The cell was hot and had no windows.

We had two buckets in the cell, one for urine and one for faeces. All 20 of us had to share the two buckets to defecate and urinate. The buckets remained in the cell until the were taken out the following day. I could not eat as the stench in the cell was so bad that it was impossible for me to eat in that condition.

He was kept in prison for four weeks before being sent back to the Detention Centre back to the hot, overcrowded, stinking dorms, clogged toilets and showers filled with up to a foot of dirty water.

On June 16, 2017, after his lawyers applied for Habeas Corpus Bojang was finally taken to court. He was given no notice of where he was being taken or why, and after being manhandled and dragged to a car like a criminal he was shackled to prisoners who he later found out were charged with murder.

Chief Justice Isaacs determined he had been wrongfully imprisoned and granted his immediate release pending a response from the United Nations High Commissioner for Refugees (UNHCR) to his application for political asylum. He was not immediately released, but rather unlawfully detained once again, re-shackled to accused murderers, and brought to a police station to spend the next four hours in a cell with nothing to eat or drink.

In January 2018, Bojang applied for a work permit to sustain himself while in The Bahamas and paid the relevant fee. They government has refused to even acknowledge his application for three years, leaving him penniless and desperate.

Ever since he was freed, Bojang has been seeking justice for the violation of his constitutional rights, but this has been delayed and resisted at every turn by the Attorney Generals office. When the matter finally came to trial on November 17, 2020 the only position put forward by the government was to flatly deny that he was ever falsely imprisoned and assert his treatment was humane. They have provided no documents concerning his detention, despite the court ordering discovery..

The Supreme Court concluded trial on November 18, and is considering Bojangs request for damages for false imprisonment and inhumane treatment. On 5 August 2020, Bojang learned that the UNHCR had upheld his refugee status, giving him the right to be protected from forcible return to the Gambia until such time as he is able to return safely and with dignity.

The Bahamas became a signatory of the United Nations Convention and Protocol Relating to the Status of Refugees in 1993. The main thrust of this agreement is the principle of non-refoulement, which asserts that a refugee should not be returned to a country where they face serious threats to their life or freedom. This is now considered a core rule of customary international law.

On December 10, 2018, the Bahamas became one of the 153 signatories to the Global Compact for Migration (GCM), which emphasises the safety, dignity, and human rights and fundamental freedoms of all migrants, regardless of their migratory status.

The government claims on its website that it seeks to adhere to these agreements, adding that in the identification and protection of asylum seekers, the Immigration Department maintains a transparent process, which conforms to international standards.

To say that The Bahamas violated both its own Constitution and its international obligations with regard to Bojang would be an understatement of epic proportions. In his and so many other cases related to migration, the government routinely tramples upon its responsibilities, acting as if basic human rights and international law simply do not exist. The harrowing tale of his treatment echos that of countless poor souls who have the bad luck to end up in the hands of Bahamian authorities.

Meanwhile, at the same time that this government continues to abuse Bojang, it is bringing legislation to codify the asylum seeking process into law, whereby anyone unable or unwilling to return to his country of origin owing to a well-founded fear of persecution for reasons of race, religion, nationality, membership of a particular social group or because he holds a particular political opinion is to be granted asylum and have the right to live and work in The Bahamas. No more and no less than Ousmane Bojang asked for.

His ordeal is about far more than immigration laws or UN standards; it speaks to who we are as a nation. To whether or not we have a fundamental regard for fairness, justice and basic human decency. In essence, laws are only as good as a societys willingness to enforce them.

See the article here:

INSIGHT: From persecution to prison to poverty a political refugee's five-year ordeal in The Bahamas - Bahamas Tribune

Posted in Bahamas | Comments Off on INSIGHT: From persecution to prison to poverty a political refugee’s five-year ordeal in The Bahamas – Bahamas Tribune

Joe Giudice Is Headed to the Bahamas in the New Year for Celebrity Boxing! – WSMV Nashville

Posted: at 8:55 pm

'); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).append('"+val.ihtml+""); $("#expandable-weather-block .weather-index-alerts").show(); $("#expandable-weather-block .modal-body h2").css({"font-family":"'Fira Sans', sans-serif", "font-weight":"500", "padding-bottom":"10px"}); $("#expandable-weather-block .modal-body p").css({"font-size":"14px", "line-height":"24px"}); $("#expandable-weather-block .modal-body span.wxalertnum").css({"float":"left", "width":"40px", "height":"40px", "color":"#ffffff", "line-height":"40px", "background-color":"#888888", "border-radius":"40px", "text-align":"center", "margin-right":"12px"}); $("#expandable-weather-block .modal-body b").css("font-size", "18px"); $("#expandable-weather-block .modal-body li").css({"font-size":"14px", "line-height":"18px", "margin-bottom":"10px"}); $("#expandable-weather-block .modal-body ul").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body pre").css({"margin-bottom":"24px"}); $("#expandable-weather-block .modal-body img").css({"width":"100%", "margin-bottom":"20px", "borderWidth":"1px", "border-style":"solid", "border-color":"#aaaaaa"}); $("#expandable-weather-block .modal-body #mrd-alert"+ alertCount).css({"borderWidth":"0", "border-bottom-width":"1px", "border-style":"dashed", "border-color":"#aaaaaa", "padding-bottom":"10px", "margin-bottom":"40px"}); }); } function parseAlertJSON(json) { console.log(json); alertCount = 0; if (Object.keys(json.alerts).length > 0) { $("#mrd-wx-alerts .modal-body ").empty(); } $.each(json.alerts, function(key, val) { alertCount++; $("#mrd-wx-alerts .alert_count").text(alertCount); $("#mrd-wx-alerts .modal-body ").append(''); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(""+val.title+""); // if (window.location.hostname == "www.kmov.com" || window.location.hostname == "www.kctv5.com" || window.location.hostname == "www.azfamily.com" || window.location.hostname == "www.kptv.com" || window.location.hostname == "www.fox5vegas.com" || window.location.hostname == "www.wfsb.com") { if (val.poly != "" && val.polyimg != "") { $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } else if (val.fips != "" && val.fipsimg != "") { // $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(''); } // } //val.instr = val.instr.replace(/[W_]+/g," "); $("#mrd-wx-alerts .modal-body #mrd-alert"+ alertCount).append(val.dhtml+"



Joe Giudice Is Headed to the Bahamas in the New Year for Celebrity Boxing! - WSMV Nashville

Posted in Bahamas | Comments Off on Joe Giudice Is Headed to the Bahamas in the New Year for Celebrity Boxing! – WSMV Nashville

US Donates Additional $20K to COVID Fight in The Bahamas – US Embassy in The Bahamas

Posted: at 8:55 pm

Commander Sonia Miller of the Royal Bahamas Defence Force (left) greets U.S. Embassy Senior Defense Official, Commander Kevn Self (right), upon receiving $20,000 in equipment to aid in the fight against COVID-19 in The Bahamas| November 20, 2020 | Nassau, The Bahamas

On Friday, November 20, the U.S. Embassy in Nassau delivered $20,000 in additional equipment to help the fight against COVID-19 in The Bahamas. U.S. Northern Command (NORTHCOM) donated six custom-made internal partitions for mobile shelters being used to screen COVID-19 patients, allowing them to better isolate patients and prevent the spread of the virus.

U.S. Embassy Senior Defense Official, Commander Kevin Self, delivered the donation to Commander Sonia Miller of the Royal Bahamas Defence Force, and Captain Stephen Russell, Director of the National Emergency Management Agency (NEMA), at the South Beach Clinic on New Providence.

In September of 2020, the U.S. Embassy donated ten mobile shelters to NEMA to aid in disaster relief, and the Ministry of Health (MoH) expressed interest in using some of the shelters in the fight against COVID-19. Within weeks, the MoH had begun using two of the shelters at the South Beach Clinic to screen patients and conduct testing. However, Minister of Health Renward Wells asked whether it would be possible to create partitions inside the shelters that could help more effectively isolate patients and prevent infection.

Exemplifying the ongoing partnership between the United States and The Bahamas, Commander Self took Minister Wells request to NORTHCOM, who then then worked with Regulus Global (the company that originally manufactured the shelters) to create custom-made partitions for the shelters. When installed, the partitions create three smaller rooms within the larger shelter, keeping patients isolated from one another and preventing the spread of infection.

NORTHCOM provided six partitions, giving Ministry of Health officials the flexibility to meet current and future needs.

By U.S. Embassy Nassau | 24 November, 2020 | Topics: Events, News, Press Releases

Read this article:

US Donates Additional $20K to COVID Fight in The Bahamas - US Embassy in The Bahamas

Posted in Bahamas | Comments Off on US Donates Additional $20K to COVID Fight in The Bahamas – US Embassy in The Bahamas

Bahamas To Buy Off Hurricanes With Sand Dollars. – The St. Kitts-Nevis Observer

Posted: at 8:55 pm

FREEPORT, Grand Bahama Minister of State for Grand Bahama, Senator Kwasi Thompson got an opportunity to inform Latin America countries, as well as a number of Caribbean nations about the Bahamas strides thus far in the countrys digital transformation, as well as the plans to expand that transformation as time goes on.

Minister Thompson, who is also responsible for electronic communication and the governments Digitization program spoke at the 14th annual meeting of Red GEALC Sixth Ministerial Meeting of Digital Government, which was hosted by Costa Rica and held virtually.

The virtual conference, brought together ICT Ministers from the Caribbean and Latin America.

During his presentation Minister Thompson pointed out that The Bahamas took on its digital journey with the overarching goal of delivering services and programs that would foster transparency, effectiveness, efficiency and cost reduction.

He noted that a focused approach on what the user/customer says would make their experience better, and programs that would achieve this is the key.

So we focused on streamlining (1) to reduce or remove the movement of paper or documents between customer and government, and agency-to-agency (2) to reduce or remove the need for the public officer to review and approve where it adds no value, said Minister Thompson.

Our challenge was to get public officers to un-think how things are done and to rethink a better way for themselves and their customers.

Our Bahamas Electronic Cabinet Management Information System (BECMIS) is a good example of our focused approach. It is a six-month project with releases in six-week intervals. Users, from clerks in the Cabinet Office to my cabinet colleagues, are involved from the design to testing.

We are successfully battling through the elimination of steps, the rethinking process flow, and redesigning documents. When completed, there will be end-to-end handling of information and proceedings electronically. We will see digital collaboration between agencies and collaboration between cabinet colleagues.

The Minister noted that The Bahamas is excited about its Proof-of-Concept Interoperability Platform which is currently in beta test mode. This platform, he added, is allowing government services to share information from disparate data sources, securely.

Due to built-in verifications and validations, the user provides little to no information for renewal services and in most instances, public officers will only have to review and approve requests or transactions that are an exception, explained Minister Thompson.

To reach this level of automation the IT agency worked closely with the service provider to streamline processes, engaging them from design to testing. The platform in its POC stage will allow for renewal of drivers license, renewal of passport, a request for customers own birth certificate or marriage certificate.

Also in pilot mode is the launch of the Sand Dollar, The Bahamas digital currency. The Central Bank in partnership with authorized Payment Service Providers reaches the banked and the unbanked. The government has also put forward the Digital Assets and Registered Exchanges Bill 2020 (DARE) aimed at establishing the framework for regulation of the issuance, sale and trade of digital assets in and from within The Bahamas.

Minister Thompson said that due to the COVID-19 pandemic, agencies have accelerated their digital programs, including the Food Assistance program, the Bahamas Feeding Network, virtual school and parks and public spaces are being equipped to provide internet access.

He added that through all of these ICT initiatives there is a strong realization of the need for growing capacity in various specialized fields, in application development and IT operations, but also in business analysis, change management, procurement, and public relations.

What is Project Sand Dollar?

Project Sand Dollar is the initiative embarked by Central Bank of The Bahamas to issue its own digital version of the Bahamian dollar as well as implement the appropriate digital payments system infrastructure to sufficiently underpin the operation of a digital currency ecosystem.

Hurricanes have been ravaging the Bahamas for centuries.

According to travel advice website TripSavvy,a hurricane passes close to the Bahamas every other year on average. In addition, a hurricane makes a direct landfall on the islands once every four years on average. Natural disasters can be a big-time hassle for tourists. Whats worse is that these storms often devastate the Bahamas ability to conduct trade and commerce.

On Sept. 1, 2019 the Grand Bahama Island and Abaco Islands were struck by one of the strongest hurricanes in history. Hurricane Dorian was a category five storm that packed sustained winds that reached 185 miles per hour. In addition to the strong gusts of wind, Hurricane Dorian summoned storm surges that formed water walls as high as 20 feet. According to Hubert Minnis, prime minister of the Bahamas, thestorm system left a generational devastation on the islands.

Although Sand Dollar is a cryptocurrency like bitcoin or Ethereum, it offers unique characteristics.

According to officials, Sand Dollars will be introduced in the form of a digital wallet or e-wallet. Users will be able to access it through a smartphone application. The digital wallet will also offer security features that enable users to safely save payment details as well as passwords for various payment methods.

These functionalities allow users to complete transactions using near-field communications technology. Central Bank Governor John Rolle said Project Sand Dollar can potentially improve the resilience of the country when facing natural disasters.

The central bank governor has said that Project Sand Dollar would offer the following benefits:

See the original post:

Bahamas To Buy Off Hurricanes With Sand Dollars. - The St. Kitts-Nevis Observer

Posted in Bahamas | Comments Off on Bahamas To Buy Off Hurricanes With Sand Dollars. – The St. Kitts-Nevis Observer

Limeade Bahamas provides breakfast for 400 in the Englerston community – EyeWitness News

Posted: at 8:55 pm

NASSAU, BAHAMAS Bahamian-owned company Limeade and The Munroe Foundation, along with Englerston MP Glenys Hanna-Martin, hosted Community Cares at the Montell Heights Community Centre on Mantol Street on Saturday to distribute breakfast and Limeade to residents of the area.

Limeade owner Joshua Miller stated, We realize the impact that weve had on the residences in the previous communities and we will continue the initiative with the goal of reaching as many communities as we can. As many people prepare to celebrate Thanksgiving this week, we would like to continue doing our part and spreading joy through helping others. Knowing that you have made a difference in some way to someone is a good feeling.

At the launch of the initiative, the statement noted, 250 lunches and gallons of Limeade were distributed and as a result, several additional partners have agreed to join and continue to join the initiative.

Miller continued, Thanks to our partners, on our second initiative, residents in the area were able to come to the community center and 400 plates of food and gallons of Limeade were distributed. Today (Saturday, November 21), we are able to yet again distribute 400 plates of food and limeade beverages.

He added: Today would not have been possible without our partners and we are grateful to those that assisted in any way to make it happen. I would like to recognize and say a special thank you to Purity Bakery, Bakertilly, Bahamas P and L Bakery, Chef Lorre, Alfredo Foodie, U Stream Us radio station, Believe Wines, Bahamas Medical and Surgical Supplies, Green Thumb Group, Morning Moves with Bowflex Barbie and Jay Fitness.

The statement also read: With community partnerships being one of their main initiatives, The Munroe Foundation continues to play a major role through their generous contributions and their time.

Its core focus, according to the statement, is to continue to have a heart for people; a goal which it states always has and always will be what the Munroe Foundation stands for.

More here:

Limeade Bahamas provides breakfast for 400 in the Englerston community - EyeWitness News

Posted in Bahamas | Comments Off on Limeade Bahamas provides breakfast for 400 in the Englerston community – EyeWitness News